Achieving the Promise: Transforming Mental Health Care in America. Pub no SMA-03-3832. Rockville, Md, Department of Health and Human Services, New Freedom Commission on Mental Health, 2003
Krupa T: Employment, recovery, and schizophrenia: integrating health and disorder at work. Psychiatric Rehabilitation Journal 28:8—15, 2004
Resnick S, Rosenheck RA, Lehman AF: An exploratory analysis of correlates of recovery. Psychiatric Services 55:540—547, 2004
Provencher HL, Gregg R, Crawford SM, et al: The role of work in the recovery of persons with psychiatric disabilities. Psychiatric Rehabilitation Journal 26:132—144, 2002
Mark TL, Dirani R, Slade E, et al: Access to new medications to treat schizophrenia. Journal of Behavioral Health Services and Research 29:1—15, 2002
Slade E, Salkever D: Symptom effects on employment in a structural model of mental illness and treatment: analysis of patients with schizophrenia. Journal of Mental Health Policy and Economics 4:25—34, 2001
Swanson JW, Swartz MS, Elbogen EB: Effectiveness of atypical antipsychotic medications in reducing violent behavior among persons with schizophrenia in community-based treatment. Schizophrenia Bulletin 30:3—20, 2004
Slade EP, Salkever DS, Rosenheck R, et al: Cost-sharing requirements and access to mental health care among Medicare enrollees with schizophrenia. Psychiatric Services 56:960—966, 2005
Ascher-Svanum H, Faries D, Zhu B, et al: Medication adherence and long-term functional outcomes in the treatment of schizophrenia in usual care. Journal of Clinical Psychology 67:453—460, 2006
Faries D, Ascher-Svanum H, Zhu B, et al: A prospective study of monotherapy in the naturalistic treatment of schizophrenia with atypical antipsychotics. BMC Psychiatry 5:26, 2005
Cook J, Mulkern G, Grey D, et al: Effects of unemployment rate on vocational outcomes in a randomized trial of supported employment for individuals with severe mental illness. Journal of Vocational Rehabilitation 25:71—84, 2006
Russinova Z, Wewiorski N, Lyass A, et al: Correlates of vocational recovery for persons with schizophrenia. International Review of Psychiatry 14:303—311, 2002
Wewiorski N, Fabian E: Association between demographic and diagnostic factors and employment outcomes for people with psychiatric disabilities: a synthesis of recent research. Mental Health Services Research 6:9—21, 2004
Rosenheck R, Leslie D, Keefe R, et al: Barriers to employment for people with schizophrenia. American Journal of Psychiatry 163:1—7, 2006
Kay SR, Fiszbein A, Opler LA: The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophrenia Bulletin 13:261—276, 1987
Montgomery SA, Åsberg M: A new depression scale designed to be sensitive to change. British Journal of Psychiatry 134:382—389, 1979
Guy W (ed): Assessment Manual for Psychopharmacology. Publication ADM 76-338. Washington, DC, US Department of Health, Education, and Welfare, 1976
Simpson G, Angus J: A rating scale for extrapyramidal side effects. Acta Psychiatrica Scandinavica Supplementum 212:11—19, 1970
US. Department of Labor, Bureau of Labor Statistics, Local Area Unemployment Statistics (LAUS). Available at data.bls.gov. Accessed May 2004.
Ehrenberg RG, Smith RS: Modern Labor Economics: Theory and Public Policy, 7th ed. Reading, Mass, Addison Wesley Longman, 2000
Wooldridge JM: Econometric Analysis of Cross Section and Panel Data. Cambridge, Mass, MIT Press, 2002
Stata User's Guide, Release 8. College Station, Tex, Stata Corp, 2003
Salkever DS, Slade EP, Karakus MC: Gender-specific patterns of employment and employment transitions for persons with schizophrenia: evidence from the Schizophrenia Care and Assessment Program (SCAP), in The Economics of Gender and Mental Illness: Research in Human Capital and Development. Edited by Marcotte DE, Wilcox-Gök V. Amsterdam, Elsevier, 2004.
Salkever D, Slade EP, Karakus MC: Differential effects of atypical vs typical antipsychotic medication on earnings of schizophrenia patients: estimates from a prospective naturalistic study. PharmacoEconomics 24:123—139, 2006
Stroup TS, McEvoy JP, Swartz MS, et al: The National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project: schizophrenia trial design and protocol development. Schizophrenia Bulletin 29:15—31, 2003
Marwaha S, Johnson S: Schizophrenia and employment: a review. Social Psychiatry and Psychiatric Epidemiology 39:337—349, 2004
Rosenheck RA, Stroup S, Keefe R, et al: Measuring outcome priorities and incorporating preferences in mental health status assessment of people with schizophrenia. British Journal of Psychiatry 187:529—536, 2005
Mechanic D, Bilder S, McAlpine DD: Employing persons with serious mental illness. Health Affairs 21(5):242—253, 2002
Lehman AF, Goldberg R, Dixon LB, et al: Improving employment outcomes for persons with severe mental illness. Archives of General Psychiatry 59:165—172, 2002
Cook JA, Leff HS, Blyler CR, et al: Results of a multisite randomized trial of supported employment interventions for individuals with severe mental illness. Archives of General Psychiatry 62:505—512, 2005
McGurk SR, Mueser KT: Cognitive functioning, symptoms, and work in supported employment: a review and heuristic model. Schizophrenia Research 70:147—173, 2004
Razzano LA, Cook JA, Burke-Miller J K, et al: Clinical factors associated with employment among people with severe mental illness: findings from the Employment Intervention Demonstration Program. Journal of Nervous and Mental Disease 193:705—713, 2005
Swartz MS, Wagner HR, Swanson JW, et al: Substance use and psychosocial functioning in schizophrenia among new enrollees in the NIMH CATIE Study. Psychiatric Services 57:1110—1116, 2006
Goldberg RW, Lucksted A, McNary S, et al: Correlates of long-term unemployment among inner-city adults with serious and persistent mental illness. Psychiatric Services 52:101—103, 2001
Catalano R, Drake RE, Becker DR et al: Labor market conditions and employment of the mentally ill. Journal of Mental Health Policy and Economics 2:51—54, 1999
Percudani M, Barbui C, Tansella M: Effect of second-generation antipsychotics on employment and productivity in individuals with schizophrenia: an economic perspective. PharmacoEconomics 22:701—718, 2004
Salkever DS, Slade EP: Employment retention by persons with schizophrenia employed in non-assisted jobs. Journal of Rehabilitation 69:18—25, 2003
Hamilton SH, Edgtell ET, Revicki, et al: Functional outcomes in schizophrenia: a comparison of olanzapine and haloperidol in a European sample. International Clinical Psychopharmacology 15:245—255, 2000
Rosenheck R, Perlick D, Bingham S, et al: Effectiveness and cost of olanzapine and haloperidol in the treatment of schizophrenia: a randomized controlled trial. JAMA 290:2693—2702, 2003